The global oncology information systems (OIS) market size was estimated at USD 2,944.0 million in 2024 and is projected to reach USD 4,693.9 million by 2030, registering a CAGR of 8.1% from 2025 to 2030. This growth outlook reflects the growing emphasis on digital transformation in oncology care ecosystems. The increasing burden of cancer cases worldwide continues to heighten the demand for efficient technology that can support clinical decision-making and streamline patient management. As healthcare providers move toward precision oncology, the adoption of Oncology Information Systems is accelerating due to their ability to support treatment planning, automate clinical workflows, and enable personalized care. Furthermore, the gradual shift toward AI-driven treatment planning and real-time patient monitoring solutions is reshaping oncology workflows by improving accuracy, minimizing manual workload, and enhancing operational efficiency in hospitals and cancer care centers.

The rising global burden of cancer is one of the strongest drivers for OIS adoption. According to the World Health Organization (WHO), cancer persists as a leading cause of mortality globally, being responsible for approximately one in every six deaths. In addition, the Global Cancer Statistics 2022 reported 19.96 million new cancer cases and 9.73 million deaths, with cancer types such as lung, colorectal, liver, and breast cancer contributing substantially to mortality rates. The increasing incidence has created urgent demand for solutions capable of handling large volumes of patient data, supporting clinical documentation, and enabling coordinated multidisciplinary care. In this context, oncology information systems are being utilized to support efficient data management, radiation therapy planning, personalized treatment decisions, and long-term patient monitoring, making them highly valuable tools within modern oncology departments.

Growing investments in cancer research, diagnostics, and radiology infrastructure further contribute to the rising adoption of OIS. For example, India’s cervical cancer elimination program, supported by the Indian Council of Medical Research (ICMR), aims to expand screening and diagnostic accessibility, areas where OIS can enhance program effectiveness by centralizing patient records, tracking progress, and reducing administrative burden. Similarly, the Japan International Cooperation Agency (JICA) allocated USD 75 million during 2019–2023 to strengthen oncology infrastructure across the Asia Pacific region, preparing hospitals for digital oncology solutions like OIS. Meanwhile, research initiatives such as Johns Hopkins University’s USD 20.9 million Cancer Moonshot project and the Accuray-Limbus AI partnership focused on AI-assisted auto-contouring signify advancements that enhance radiotherapy planning precision. Such initiatives are enabling sophisticated OIS platforms capable of integrating imaging, radiotherapy tools, and automated treatment mapping for improved clinical outcomes.

The integration of artificial intelligence (AI) and machine learning (ML) is revolutionizing OIS functionality and expanding its use in early detection and personalized treatment strategies. AI-enabled OIS solutions can analyze data from electronic health records, genomic sequencing, and imaging modalities to automate administrative processes, predict treatment outcomes, and identify tumor progression trends. A notable example was reported in July 2024, when MIT and ETH Zurich developed an AI model capable of identifying stages of Ductal Carcinoma in Situ (DCIS) using breast tissue images. This innovation speeds up diagnostic processes and reduces reliance on extensive manual microscopic analysis. Such advancements highlight how AI integration within OIS supports faster diagnosis, reduces errors, and enables targeted interventions, ultimately improving patient quality of care and survival rates.

Key Market Trends & Insights:

  • North America held the largest revenue share of 39.67% in 2024, driven by advanced healthcare infrastructure and high technological adoption in oncology care. The U.S. accounted for the largest share within North America, supported by a high cancer prevalence across various age groups and growing demand for innovative oncology information systems.
  • The Asia Pacific region is expected to exhibit the fastest growth during the forecast period, attributed to rising cancer incidence, expanding healthcare spending, and rapid digital transformation across hospitals and cancer institutes.
  • By products & services, the solutions segment dominated with a 73.99% revenue share in 2024 and is expected to grow at the fastest CAGR due to increasing use of treatment planning software, patient data management tools, and decision support platforms. Meanwhile, the professional services segment is projected to grow significantly, as hospitals increasingly outsource installation, customization, and maintenance services to streamline workflows.
  • By application, medical oncology accounted for the largest share of 61.81% in 2024 and is expected to grow at the highest CAGR from 2025 to 2030, supported by rising adoption of systemic therapies and targeted drug treatment planning. The surgical oncology segment is also anticipated to expand notably with growing use of digital tools in pre-operative planning.
  • By end-use, hospitals & diagnostic imaging centers represented 47.53% of the total revenue in 2024, owing to high patient inflow and advanced treatment facilities. Additionally, ablation care centers and cancer care centers are projected to record the fastest CAGR due to the rising preference for minimally invasive tumor ablation procedures. These facilities increasingly implement OIS for real-time imaging integration, ablation device connectivity, and centralized patient monitoring, enhancing precision and safety during therapy.

Order a free sample PDF of the Oncology Information Systems Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

  • 2024 Market Size: USD 2,944.0 Million
  • 2030 Projected Market Size: USD 4,693.9 Million
  • CAGR (2025-2030): 8.1%
  • North America: Largest market in 2024

Key Companies & Market Share Insights:

The market is highly fragmented, with many small and large players operating in this space. This leads to intense competition between smaller players to sustain their position. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth. Some of the emerging players in the market are OncoLens, Inventigen Technologies Pvt. Ltd., Prowess, Inc. etc.

Key Players

  • Accuray Incorporated
  • Elekta
  • BrainLab
  • DOSIsoft SA
  • FLATIRON HEALTH
  • RaySearch Laboratories
  • Oracle (Cerner Corporation)
  • Koninklijke Philips N.V.
  • Varian Medical Systems, Inc. (Siemens Healthineers).

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the global oncology information systems market is poised for strong growth, driven by the escalating burden of cancer and the increasing demand for precision-based treatment approaches. The integration of AI and machine learning is enhancing decision support, accelerating diagnosis, and improving treatment planning, making OIS a core component of modern oncology care. Growing government initiatives, research investments, and infrastructure development across regions, particularly in Asia Pacific, are further supporting market expansion. North America currently leads the market, while emerging economies are expected to witness rapid adoption due to healthcare digitalization. Overall, the market outlook remains promising, with rising adoption of data-driven oncology platforms expected to transform patient care, optimize outcomes, and elevate the efficiency of cancer treatment systems worldwide.